Skip to main content
. 2021 Jan 8;11(1):e037793. doi: 10.1136/bmjopen-2020-037793

Table 3.

The baseline characteristics on the first day of admission

Baseline characteristics
Demographic data
 Male sex, n (%) 1006 (73.4%)
 Age (years) median (IQRs) 49.0 (40.0–59.0)
 HBV-related, n (%) 952 (69.5%)
 Cirrhosis, n (%) 973 (71.1%)
Laboratory data, median (IQRs)
 Total bilirubin (mg/dL) 3.9 (1.5–13.7)
 INR 1.41 (1.17–1.79)
 Serum creatinine (mg/dL) 0.78 (0.65–0.96)
 ALT (U/L) 82 (29–383)
 AST (U/L) 101 (46–265)
 γ-GT (U/L) 82 (38–158)
 AKP (U/L) 125 (92–63)
 Albumin (g/L) 32.3 (28.1–37.0)
 CRP (mg/L) 7.3 (3.1–14.6)
 WBC (×109/L) 4.95 (3.69–7.06)
 Hb (g/L) 118 (94–136)
 Platelet count (×109/L) 96.0 (61.0–150.0)
 Serum sodium (mmol/L) 138 (136–141)
 Patients with AD 1083 (79.1%)
Type of AD
 Overt ascites 558 (40.7%)
 Gastrointestinal bleeding 224 (16.4%)
 HE 105 (7.7%)
 Jaundice 611 (44.6%)
 Infection 218 (15.9%)
Score
 MELD score 15 (10–22)
 Child-Pugh score 8 (7–10)
 Child-Pugh grade
 Child-Pugh A, n (%) 261 (19.1%)
 Child-Pugh B, n (%) 533 (38.9%)
 Child-Pugh C, n (%) 576 (42.0%)

AD, acute decompensation; AKP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C reactive protein; γ-GT, γ-glutamyl transferase; Hb, haemoglobin; HBV, hepatitis B virus; HE, hepatic encephalopathy; INR, international standardisation ratio; MELD, the Model for End-stage Liver Disease; WBC, white cell count.